Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Inventory Average (2016 - 2025)

Historic Inventory Average for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $1.6 million.

  • International Stem Cell's Inventory Average rose 1221.86% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 1221.86%. This contributed to the annual value of $1.2 million for FY2024, which is 887.8% down from last year.
  • As of Q3 2025, International Stem Cell's Inventory Average stood at $1.6 million, which was up 1221.86% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Inventory Average ranged from a high of $1.6 million in Q3 2025 and a low of $986000.0 during Q1 2021
  • Its 5-year average for Inventory Average is $1.3 million, with a median of $1.3 million in 2023.
  • As far as peak fluctuations go, International Stem Cell's Inventory Average crashed by 1594.2% in 2021, and later skyrocketed by 2707.91% in 2022.
  • Quarter analysis of 5 years shows International Stem Cell's Inventory Average stood at $1.2 million in 2021, then grew by 20.49% to $1.4 million in 2022, then fell by 7.82% to $1.3 million in 2023, then decreased by 1.82% to $1.3 million in 2024, then rose by 24.0% to $1.6 million in 2025.
  • Its Inventory Average stands at $1.6 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.2 million for Q1 2025.